pyrrolidonecarboxylic acid has been researched along with s 2366 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallimore, M; Machin, SJ; Mackie, IJ | 1 |
| Egawa, H; Komiyama, Y; Murakami, T; Murata, K; Okubo, S; Yasunaga, K | 1 |
| Castellino, FJ; Jhingan, A; Zhang, L | 1 |
| Broze, GJ; Gailani, D | 1 |
| Colman, RW; Pixley, RA; Scott, CF | 1 |
| Conkie, JA; Davidson, JF; McCall, F; Walker, ID | 1 |
| Colman, RW; Scott, CF; Seaman, FS; Sinha, D; Walsh, PN | 1 |
| Briseid, K; Haug, K; Hoem, NO; Johannesen, S | 1 |
| Drohan, WN; Kolen, B; Orthner, CL | 1 |
| Aznar, J; España, F; Estellés, A; Gilabert, J; Hendl, S | 1 |
| Bleeker, WK; Hack, CE; Levi, M; Minnema, MC; Pajkrt, D; Roem, D; ten Cate, H; van Deventer, SJ; Wuillemin, WA | 1 |
| Griffin, JH; Rintelen, C; Yegneswaran, S | 1 |
| Badellino, KO; Marcinkiewicz, M; Sinha, D; Walsh, PN | 1 |
| Lear, JD; Marcinkiewicz, M; Sinha, D; Walsh, PN | 1 |
| Mowbray, SL; Nickolaus, N; Schedin-Weiss, S; Sun, W; Tingsborg, S; Ubhayasekera, W; Zhu, T | 1 |
| Bajaj, SP; Gailani, D; Geng, Y; Messer, A; Smith, SB; Sun, MF; Verhamme, IM | 1 |
| Farcaş, E; Fillet, M; Pochet, L | 1 |
17 other study(ies) available for pyrrolidonecarboxylic acid and s 2366
| Article | Year |
|---|---|
Contact factor proteases and the complexes formed with alpha 2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates.
Topics: alpha-Macroglobulins; Amides; Cold Temperature; Contraceptives, Oral; Diagnostic Errors; Diatomaceous Earth; Drug Therapy, Combination; Factor XIa; Female; Humans; Kaolin; Male; Oligopeptides; Precipitin Tests; Protease Inhibitors; Protein C; Pyrrolidonecarboxylic Acid | 1992 |
Purification of factor XIa inhibitor from human platelets.
Topics: Amino Acid Sequence; Amyloid beta-Protein Precursor; Blood Coagulation; Blood Platelets; Chromatography, Affinity; Chromatography, Gel; Chromogenic Compounds; Electrophoresis, Polyacrylamide Gel; Factor XIa; Humans; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid; Sequence Homology; Serine Proteinase Inhibitors | 1992 |
Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity.
Topics: 1-Carboxyglutamic Acid; Amino Acid Sequence; Base Sequence; Blood Coagulation; Cell Line; Chromogenic Compounds; DNA; Electrophoresis, Polyacrylamide Gel; Humans; Kidney; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligopeptides; Partial Thromboplastin Time; Protein C; Pyrrolidonecarboxylic Acid; Structure-Activity Relationship; Transfection | 1992 |
Factor XI activation in a revised model of blood coagulation.
Topics: Blood Coagulation; Chromogenic Compounds; Dextran Sulfate; Factor XI; Factor XIIa; Hemostasis; Kininogens; Macromolecular Substances; Models, Biological; Oligopeptides; Pyrrolidonecarboxylic Acid; Receptors, Cell Surface; Receptors, Thrombin; Recombinant Proteins; Thrombin | 1991 |
A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
Topics: Colorimetry; Factor XI; Factor XII; Factor XIIa; Humans; Kinetics; Kininogens; Microchemistry; Molecular Weight; Oligopeptides; Pyrrolidonecarboxylic Acid; Serine Endopeptidases | 1987 |
Measurement of protein C in plasma--a fully automated assay.
Topics: Anticoagulants; Autoanalysis; Clinical Enzyme Tests; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Protein C; Pyrrolidonecarboxylic Acid; Thrombosis | 1987 |
Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Chromogenic Compounds; Factor XI; Factor XI Deficiency; Factor XIa; Humans; Kininogens; Oligopeptides; Prekallikrein; Protease Inhibitors; Pyrrolidonecarboxylic Acid; Rabbits; Radioimmunoassay; Trypsin Inhibitors | 1984 |
Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
Topics: Adult; Contraceptives, Oral; Enzyme Activation; Factor XI; Factor XIa; Factor XII; Factor XII Deficiency; Female; Hemophilia B; Humans; Kallikreins; Kininogens; Male; Oligopeptides; Plant Proteins; Prekallikrein; Protease Inhibitors; Pyrrolidonecarboxylic Acid; Trypsin Inhibitors | 1995 |
A sensitive and facile assay for the measurement of activated protein C activity levels in vivo.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antithrombin III; Blood Specimen Collection; Chromogenic Compounds; Enzyme Activation; Heparin; Humans; Immunosorbent Techniques; Microspheres; Molecular Sequence Data; Oligopeptides; Protein C; Pyrrolidonecarboxylic Acid; Sensitivity and Specificity | 1993 |
Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
Topics: alpha 1-Antitrypsin; Amino Acid Sequence; Chromogenic Compounds; Enzyme-Linked Immunosorbent Assay; Female; Genital Neoplasms, Female; Heparin; Humans; Male; Molecular Sequence Data; Oligopeptides; Plasminogen Inactivators; Protein C; Protein C Inhibitor; Pyrrolidonecarboxylic Acid; Risk Factors; Sensitivity and Specificity; Thromboembolism | 1993 |
Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.
Topics: Adult; Blood Coagulation; Chromogenic Compounds; Complement C1 Inactivator Proteins; Endotoxemia; Endotoxins; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Factor XI; Factor XIa; Humans; Kallikreins; Oligopeptides; Protease Inhibitors; Pyrrolidonecarboxylic Acid; Thrombin | 1998 |
Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation.
Topics: Amino Acid Substitution; Anticoagulants; Chromogenic Compounds; Dose-Response Relationship, Drug; Factor V; Factor Va; Factor VIIIa; Humans; Kinetics; Mutagenesis, Site-Directed; Oligopeptides; Partial Thromboplastin Time; Protein C; Protein S; Pyrrolidonecarboxylic Acid; Recombinant Proteins; Thrombin | 2001 |
Allosteric modification of factor XIa functional activity upon binding to polyanions.
Topics: Allosteric Regulation; Dansyl Compounds; Dextran Sulfate; Factor X; Factor XIa; Heparin; Kinetics; Oligopeptides; Polyelectrolytes; Polymers; Pyrrolidonecarboxylic Acid; Spectrometry, Fluorescence | 2004 |
Factor XIa dimer in the activation of factor IX.
Topics: Amino Acid Substitution; Cell Line; Cysteine; Dextran Sulfate; Dimerization; Factor IX; Factor XIa; Factor XIIa; Glycine; Humans; Hydrolysis; Oligopeptides; Partial Thromboplastin Time; Platelet Activation; Pyrrolidonecarboxylic Acid; Substrate Specificity; Thrombin | 2005 |
Zinc ions bind to and inhibit activated protein C.
Topics: Allosteric Regulation; Binding Sites; Blood Coagulation; Calcium; Chlorides; Chromogenic Compounds; Dose-Response Relationship, Drug; Enzyme Inhibitors; Factor Va; Humans; Kinetics; Models, Molecular; Oligopeptides; Protein Binding; Protein C; Protein Conformation; Pyrrolidonecarboxylic Acid; Spectrometry, Fluorescence; Spectrophotometry; Structure-Activity Relationship; Zinc Compounds | 2010 |
A sequential mechanism for exosite-mediated factor IX activation by factor XIa.
Topics: Arginine; Binding Sites; Binding, Competitive; Biocatalysis; Calcium; Catalytic Domain; Electrophoresis, Polyacrylamide Gel; Factor IX; Factor IXa; Factor XIa; HEK293 Cells; Humans; Kinetics; Mutation; Oligopeptides; Protein Multimerization; Proteolysis; Pyrrolidonecarboxylic Acid; Recombinant Proteins; Substrate Specificity | 2012 |
Transverse diffusion of laminar flow profiles as a generic capillary electrophoresis method for in-line nanoreactor mixing: Application to the investigation of antithrombotic activity.
Topics: Arginine; Benzamidines; Chromogenic Compounds; Electrophoresis, Capillary; Fibrinolytic Agents; Humans; Limit of Detection; Oligopeptides; Pipecolic Acids; Pyrrolidonecarboxylic Acid; Small Molecule Libraries; Sulfonamides; Thrombin | 2018 |